Also known as: Kiwi Bio
Patent-pending enzymes to break down common dietary triggers
Company is active
Event Year: 2021
Company is active
Event Year: 2021
Kiwi Biosciences is dedicated to improving the lives of the 18 million Americans affected by Irritable Bowel Syndrome (IBS). The company's mission is to enable individuals suffering from IBS to experience the simple pleasure of enjoying a meal without the debilitating worry of digestive distress. Kiwi Biosciences is developing innovative, patent-pending enzymes specifically designed to break down common dietary triggers found in food, offering a potential solution for those seeking relief from IBS symptoms and a return to a more normal and comfortable lifestyle.
Kiwi Biosciences is dedicated to improving the lives of the 18 million Americans affected by Irritable Bowel Syndrome (IBS). The company's mission is to enable individuals suffering from IBS to experience the simple pleasure of enjoying a meal without the debilitating worry of digestive distress. Kiwi Biosciences is developing innovative, patent-pending enzymes specifically designed to break down common dietary triggers found in food, offering a potential solution for those seeking relief from IBS symptoms and a return to a more normal and comfortable lifestyle.
Total Raised: Unknown (Y Combinator backed)
Last Round: Summer 2021
Total Raised: Unknown (Y Combinator backed)
Last Round: Summer 2021
Healthcare
Healthcare
Healthcare -> Consumer Health and Wellness
Healthcare -> Consumer Health and Wellness
Team size: 10
Hiring: No
Team size: 10
Hiring: No
